Parameter | MEN-WS | MEN-CONTROL | WS/CONTROL (p –ANOVA/Kruskal-Wallisa) | |||||
---|---|---|---|---|---|---|---|---|
Study 1 | Study 2 | (p) | Study 1 | Study 2 | (p) | Study 1 | Study 2 | |
TC (mmol/L) | 5.11 ± 0.78 | 4.85 ± 0.69 | 0.477 | 4.29 ± 0.80 | 4.20 ± 0.76 | 0.766 | 0.015* | 0.054 |
TG (mmol/L) | 1.30 ± 1.07 | 1.16 ± 0.68 | 0.640 | 0.98 ± 0.41 | 1.13 ± 0.60 | 0.543 | 0.242 | 0.907 |
HDL (mmol/L) | 1.65 ± 0.71 | 1.61 ± 0.68 | 0.831 | 1.50 ± 0.34 | 1.48 ± 0.34 | 0.947 | 0.398 | 0.502 |
LDL (mmol/L) | 3.53 ± 0.71 | 3.25 ± 0.70 | 0.436 | 2.77 ± 0.78 | 2.67 ± 0.68 | 0.739 | 0.020* | 0.075 |
Asprosin (ng/mL) | 44.76 ± 89.93 | 32.16 ± 73.10 | 0.769 | 54.33 ± 104.05 | 42.39 ± 70.81 | 0.733 | 0.807 | 0.794 |
Adiponectin (µg/mL) | 0.77 ± 0.29 | 1.41 ± 0.54 | 0.053 | 1.62 ± 0.81 | 1.64 ± 0.81 | 0.947 | 0.005* | 0.461 |
Resistin (ng/mL) | 1.09 ± 0.28 | 1.55 ± 0.34 | 0.006* | 1.46 ± 0.31 | 1.57 ± 0.45 | 0.436 | 0.016* | 0.909 |
Leptin (ng/mL) | 0.48 ± 0.17 | 0.87 ± 0.36 | 0.008* | 0.72 ± 0.30 | 0.73 ± 0.25 | 0.901 | 0.081 | 0.297 |